Terms: = Colorectal cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
12 results:
1. Transcription of human β-galactoside α2,6-sialyltransferase (hST6Gal I) is downregulated by curcumin through AMPK signaling in human colon carcinoma HCT116 cells.
An SY; Kim KS; Lee YC; Kim SH
Genes Genomics; 2023 Jul; 45(7):901-909. PubMed ID: 37231294
[TBL] [Abstract] [Full Text] [Related]
2. gata1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in colorectal cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract] [Full Text] [Related]
4. tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in colorectal cancer.
Huang B; Yang H; Cheng X; Wang D; Fu S; Shen W; Zhang Q; Zhang L; Xue Z; Li Y; Da Y; Yang Q; Li Z; Liu L; Qiao L; Kong Y; Yao Z; Zhao P; Li M; Zhang R
Cancer Res; 2017 Jun; 77(12):3194-3206. PubMed ID: 28446464
[TBL] [Abstract] [Full Text] [Related]
5. Decreased mRNA expression of gata1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J
Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694
[TBL] [Abstract] [Full Text] [Related]
6. Birth weight and adult cancer incidence: large prospective study and meta-analysis.
Yang TO; Reeves GK; Green J; Beral V; Cairns BJ;
Ann Oncol; 2014 Sep; 25(9):1836-1843. PubMed ID: 25015335
[TBL] [Abstract] [Full Text] [Related]
7. A systems biology approach to the global analysis of transcription factors in colorectal cancer.
Pradhan MP; Prasad NK; Palakal MJ
BMC Cancer; 2012 Aug; 12():331. PubMed ID: 22852817
[TBL] [Abstract] [Full Text] [Related]
8. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
[TBL] [Abstract] [Full Text] [Related]
9. WNT2 and human gastrointestinal cancer (review).
Katoh M
Int J Mol Med; 2003 Nov; 12(5):811-6. PubMed ID: 14533014
[TBL] [Abstract] [Full Text] [Related]
10. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Karacay H; McBride WJ; Griffiths GL; Sharkey RM; Barbet J; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2000; 11(6):842-54. PubMed ID: 11087333
[TBL] [Abstract] [Full Text] [Related]
11. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells.
Van Seuningen I; Perrais M; Pigny P; Porchet N; Aubert JP
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):675-86. PubMed ID: 10840001
[TBL] [Abstract] [Full Text] [Related]
12. Pattern of malignant tumors observed in a university hospital: a retrospective analysis.
Malik IA; Khan WA; Khan ZK
J Pak Med Assoc; 1998 May; 48(5):120-2. PubMed ID: 9813970
[TBL] [Abstract] [Full Text] [Related]
